1. Home
  2. Labeler Index
  3. Wg Critical Care, Llc
  4. NDC Product Code: 44567-811 Esmolol Hydrochloride In Water

NDC 44567-811 Esmolol Hydrochloride In Water

Esmolol Hydrochloride Injection Intravenous - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 44567-811?
  4. Esmolol Hydrochloride In Water Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk
  8. Pharmacologic Classes

Product Information

NDC Product Code:
44567-811
Proprietary Name:
Esmolol Hydrochloride In Water
Non-Proprietary Name: [1]
Esmolol Hydrochloride
Substance Name: [2]
Esmolol Hydrochloride
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s): [4]
  • Intravenous - Administration within or into a vein or veins.
    • Labeler Name: [5]
    Wg Critical Care, Llc
    Labeler Code:
    44567
    Product Label ID:
    60b10020-f802-4fef-a487-0f11eca246c5
    FDA Application Number: [6]
    NDA205703
    Marketing Category: [8]
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date: [9]
    12-04-2017
    Listing Expiration Date: [11]
    12-31-2025
    Exclude Flag: [12]
    N
    Code Navigator:

    Code Structure Chart

    Product Details

    What is NDC 44567-811?

    The NDC code 44567-811 is assigned by the FDA to the product Esmolol Hydrochloride In Water which is a human prescription drug product labeled by Wg Critical Care, Llc. The generic name of Esmolol Hydrochloride In Water is esmolol hydrochloride. The product's dosage form is injection and is administered via intravenous form. The product is distributed in a single package with assigned NDC code 44567-811-10 10 bag in 1 carton / 250 ml in 1 bag. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Esmolol Hydrochloride In Water?

    Each bag is for single patient use only and does not contain any preservatives. Once drug has been withdrawn from ready-to-use bag, the infusion of the bag contents should commence immediately and complete within 24 hours. Any unused portion is to be discarded.Do not remove unit from overwrap until ready to use. Do not use if overwrap has been previously opened or damaged. The overwrap is a moisture barrier. The inner bag maintains sterility of the solution. Tear overwrap at notch and remove premixed bag.Check for minute leaks by squeezing the inner bag firmly. If leaks are found, discard solution, as sterility may be impaired. Do not use unless the solution is clear (colorless to light yellow) and the seal is intact.Preparation for intravenous administration:•Use aseptic technique.•Suspend premixed bag from eyelet support.•Remove plastic protector from delivery port at bottom of bag.•Attach administration set.•Refer to complete directions accompanying set.Do not use plastic containers in series connections. Such use could result in an embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed.Esmolol Hydrochloride is not compatible with Sodium Bicarbonate (5%) solution (limited stability) or furosemide (precipitation). Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Premixed Bag •The medication port is to be used solely for withdrawing an initial bolus from the bag. •Use aseptic technique when withdrawing the bolus dose. •Do not add any additional medications to the bag.Figure 1. Dual Port Bag Compatibility with Commonly Used Intravenous Fluids Esmolol hydrochloride was tested for compatibility with ten commonly used intravenous fluids at a final concentration of 10 mg esmolol hydrochloride per mL. Esmolol hydrochloride was found to be compatible with the following solutions and was stable for at least 24 hours at controlled room temperature or under refrigeration: •Dextrose (5%) Injection, USP •Dextrose (5%) in Lactated Ringer’s Injection •Dextrose (5%) in Ringer’s Injection •Dextrose (5%) and Sodium Chloride (0.45%) Injection, USP •Dextrose (5%) and Sodium Chloride (0.9%) Injection, USP •Lactated Ringer’s Injection, USP •Potassium Chloride (40 mEq/liter) in Dextrose (5%) Injection, USP •Sodium Chloride (0.45%) Injection, USP •Sodium Chloride (0.9%) Injection, USP

    What are Esmolol Hydrochloride In Water Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Esmolol Hydrochloride In Water UNII Codes?

    The UNII codes for the active ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Esmolol Hydrochloride In Water?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    Which are the Pharmacologic Classes for Esmolol Hydrochloride In Water?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".